ArticleThe Journal of experimental medicine2022

High-efficiency nonviral CRISPR/Cas9-mediated gene editing of human T cells using plasmid donor DNA.

Soyoung A Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.